Top 47 Framingham Startups to Watch in 2026
Framingham, Massachusetts hosts a varied collection of 47 startups. The local business landscape has a clear focus on the biotechnology and healthcare industries.
Among them is BPGbio, a biopharma company that has secured $480M in funding. Other notable companies include the clinical-stage biotech firm Alzheon and software testing company Applause.
Below is our list of 47 Framingham startups worth keeping an eye on.
Failory's Top 10 Picks
Bose engineers high-fidelity audio equipment, including speakers, soundbars, and their world-renowned noise-canceling headphones. Their sound solutions are integrated into everything from home entertainment systems to automotive and aviation applications.
| Year Founded | 1964 |
| Founders | Amar Bose |
| Funding Amount | $430.2k |
| Startup Size | Enterprise Organization (5,001+) |
| Last Funding Status | Equity Crowdfunding |
| Top Investors | — |
BPGbio builds an AI-powered platform that combines patient biology with machine learning to accelerate drug discovery. The clinical-stage biopharma company uses this technology to de-risk the development of new therapeutics for complex diseases.
| Year Founded | 2006 |
| Founders | Niven Narain |
| Funding Amount | $480M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Private Equity |
| Top Investors | — |
Outcome Referrals developed an online platform that assesses patients for a range of medical and behavioral health issues. Their solution helps clarify diagnostic problems and connects patients with the right care providers.
| Year Founded | 2012 |
| Founders | Armen Meguerditchian, David R. Kraus |
| Funding Amount | $2M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Undisclosed |
| Top Investors | — |
Applause provides digital quality and testing services through a global community of professionals who test software on real devices. This crowd-sourced model enables businesses to identify bugs and usability issues before they impact actual customers.
| Year Founded | 2007 |
| Founders | Doron Reuveni, Roy Solomon |
| Funding Amount | $115.8M |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Series F |
| Top Investors | Goldman Sachs, Accenture, Credit Suisse, Scale Venture Partners, Edward Lando |
Variantyx develops advanced molecular diagnostic solutions that help clinicians identify genetic disorders. The company's proprietary Genomic Intelligence platform uses whole genome sequencing to provide comprehensive answers from a single test.
| Year Founded | 2014 |
| Founders | Haim Neerman, Tomer Jackman |
| Funding Amount | $136.5M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series D |
| Top Investors | Bosch Ventures, New Era Capital Partners, Kreos Capital, Pitango VC, Peregrine Ventures |
Alzheon develops oral therapies for neurodegenerative conditions, primarily targeting Alzheimer's disease. This clinical-stage biotechnology company aims to slow disease progression through its novel treatment pipeline.
| Year Founded | 2013 |
| Founders | Martin Tolar |
| Funding Amount | $366.2M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series E |
| Top Investors | Ally Bridge Group, National Institute on Aging, Alerce Medical Technology Partners, Scott H. Cohen |
Punchbowl provides a web-based platform for planning parties, complete with customizable digital invitations and greeting cards. Their service simplifies event organization by helping hosts manage guest lists and track RSVPs for any occasion.
| Year Founded | 2007 |
| Founders | Matt Douglas, Sean Conta |
| Funding Amount | $14.8M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Venture Round |
| Top Investors | Intel Capital, Contour Venture Partners, Silicon Valley Bank, SG Credit Partners, Dharmesh Shah |
DetraPel synthesizes and manufactures advanced protective coatings designed to repel liquids and stains. Their PFAS-free formulas provide a safer, more environmentally friendly alternative for both consumer and industrial applications.
| Year Founded | 2013 |
| Founders | David Zamarin |
| Funding Amount | $14M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series A |
| Top Investors | Cerity Partners Ventures, MassChallenge, Material Impact, Fitz Gate Ventures, Boro Capital |
Raven360 builds a sales readiness platform that delivers consistent content, training, and coaching to sales teams. Their software ensures sales professionals are always equipped with the most up-to-date knowledge and materials to effectively engage buyers.
| Year Founded | 2011 |
| Founders | Joe Moriarty, Vasu Ram |
| Funding Amount | $12.5M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series B |
| Top Investors | Allos Ventures, Nauta Capital, Hub Angels Investment Group, MassVentures, ZetrOZ |
Berg uses its proprietary AI platform, Interrogative Biology®, to map diseases and accelerate the development of new medicines. The clinical-stage biotech company is creating a pipeline of novel therapeutics in complex areas like oncology and neurology.
| Year Founded | 2006 |
| Founders | Niven Narain |
| Funding Amount | $200k |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Grant |
| Top Investors | Alliance of Families Fighting Pancreatic Cancer |
37 Additional Framingham Startups Worth Following
Our top 10 picks offer a great snapshot, but they only tell part of the story. The wider scene is a mix of established names and new ventures, with a strong focus on biotech and healthcare. Some are just getting started, while others are already major local employers. Here’s a look at the rest of the companies that make Framingham’s startup scene one to watch.
| Startup | Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
 DTT | Travel | 1999 | $147M | Debt Financing |
 Bluespec | Design | 2003 | $22.3M | Venture Round |
 ClubNFT | Media | 2021 | $3.9M | Seed |
 Framingham Heart Study | Healthcare | 1948 | $38M | Grant |
 Cannon Capital | Fintech | 2016 | $27.6M | Undisclosed |
 Olaris | Biotech | 2013 | — | Series B |
 Solace Therapeutics | Healthcare | 1997 | $36M | Series B |
 Veloxint | Enterprise | 2005 | $6.9M | Venture Round |
 Qura | Healthcare | 2015 | $1M | Series A |
 Princeton Review | Education | 1981 | $37M | Private Equity |
 Kephera Diagnostics | Biotech | 2017 | $4.8M | Grant |
 SCIEX | Biotech | 1970 | — | — |
 PLT4M | Media | 2013 | $2M | Venture Round |
 Trilio | Cloud | 2013 | $39M | Series B |
 T.J.Maxx | Fashion | 1976 | — | — |
 Alyce | Marketing | 2015 | $46.8M | Series B |
 examPAL | Education | 2015 | $2.2M | Venture Round |
 Towerwall | Enterprise | 1993 | — | — |
 Cantrip Seltzer | AgTech | 2020 | $138.2k | Seed |
 WoundForce | Biotech | 2015 | $500k | Seed |
 RaveMobileSafety.com | Enterprise | 2004 | $46M | Private Equity |
 Magnomer | Environment | 2020 | $50k | Seed |
 Beacon Mobility | Media | 1986 | — | Private Equity |
 Dr. Dental | Healthcare | 2004 | — | Private Equity |
 Tommy's Taxi | Logistics | 1946 | $7.9k | Grant |
 ECA | Media | 1987 | — | — |
 Anagram Therapeutics | Biotech | — | — | — |
 BRZ Insurance | InsurTech | 2017 | — | — |
 HomeGoods | Retail | 2009 | — | — |
 getWise (currently in market as wiseHer) | Marketplace | 2018 | — | — |
 IDC Financial Insights | Fintech | 1964 | — | — |
 uTest | Marketplace | 2007 | — | — |
 RadiantNano | Hardware | 2020 | — | — |
 WeCare 365 | Healthcare | 2015 | — | — |
 Cumberland Farms | Retail | 1938 | — | — |
| Bose Corporation | Hardware | 1964 | — | — |
 Boston Heart Diagnostics | Biotech | 2007 | $10.3M | Series C |
